Biomea Fusion
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.About BMEA
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
CEOMichael J. M. Hitchcock
CEOMichael J. M. Hitchcock
Employees106
Employees106
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2017
Founded2017
Employees106
Employees106
BMEA Key Statistics
Market cap95.80M
Market cap95.80M
Price-Earnings ratio-0.56
Price-Earnings ratio-0.56
Dividend yield—
Dividend yield—
Average volume1.95M
Average volume1.95M
High today$1.38
High today$1.38
Low today$1.31
Low today$1.31
Open price$1.35
Open price$1.35
Volume770.18K
Volume770.18K
52 Week high$4.59
52 Week high$4.59
52 Week low$0.8719
52 Week low$0.8719
Stock Snapshot
With a market cap of 95.8M, Biomea Fusion(BMEA) trades at $1.35. The stock has a price-to-earnings ratio of -0.56.
During the trading session on 2025-12-19, Biomea Fusion(BMEA) shares reached a daily high of $1.38 and a low of $1.31. At a current price of $1.35, the stock is +3.4% higher than the low and still -2.0% under the high.
Trading volume for Biomea Fusion(BMEA) stock has reached 770.18K, versus its average volume of 1.95M.
Over the past 52 weeks, Biomea Fusion(BMEA) stock has traded between a high of $4.59 and a low of $0.87.
Over the past 52 weeks, Biomea Fusion(BMEA) stock has traded between a high of $4.59 and a low of $0.87.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
0%
Sell
14.3%
People also own
Based on the portfolios of people who own BMEA. This list is generated using Robinhood data, and it’s not a recommendation.